Many Top Part D Plans Will Have Double-Digit Premium Increases In 2013
This article was originally published in The Pink Sheet Daily
Seven popular Medicare prescription drug plans are increasing monthly premiums by double-digit percentages for 2013, but plans under $30 should still be widely available and AARP is offering a new $15 plan, Avalere reports.
You may also be interested in...
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.
FDA/CMS Summit speakers say they've yet to see any real interest from manufacturers in putting money at risk if their products don't meet outcome measures.